Miscellaneous recommendations
On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
|
New 26/06/2023 |
NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) | NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) | Approved by NENC Medicines Subcommittee | 20/06/2023 |
|
New 26/06/2023 |
NENC Penicillin Allergy Assessment Oral Challenge and De-labelling Secondary Care - June 2023 | NENC Penicillin Allergy Assessment Oral Challenge and De-labelling Secondary Care - June 2023 | Approved by NENC Medicines Subcommittee | 20/06/2023 |
|
Updated 07/06/2022 |
NTAG Decision Summary - Biosimilars statement - June 2022 | Recommendation | Recommended | 07/06/2022 |